Aplastic and hypoproliferative anemias

22
APLASTIC AND HYPOPLASTIC ANEMIAS

Transcript of Aplastic and hypoproliferative anemias

Page 1: Aplastic and hypoproliferative anemias

APLASTIC AND HYPOPLASTIC

ANEMIAS

Page 2: Aplastic and hypoproliferative anemias

WHAT HAPPENS WHEN THE BONE MARROW SHUTS DOWN?

Page 3: Aplastic and hypoproliferative anemias

Aplastic anemia Aplastic anemia is a severe, life

threatening syndrome in which production of erythrocytes, WBCs, and platelets has failed.

Aplastic anemia may occur in all age groups and both genders.

The disease is characterized by peripheral pancytopenia and accompanied by a hypocellular bone marrow.

Page 4: Aplastic and hypoproliferative anemias

Hypocellular bone marrow in aplastic

anemia

Page 5: Aplastic and hypoproliferative anemias

Aplastic anemia PATHOPHYSIOLOGY:

The primary defect is a reduction in or depletion of hematopoietic precursor stem cells with decreased production of all cell lines. This is what leads to the peripheral pancytopenia.

Page 6: Aplastic and hypoproliferative anemias

This may be due to quantitative or qualitative damage to the pluripotential stem cell.

In rare instances it is the result of 1. Abnormal hormonal stimulation of stem

cell proliferation or 2. The result of a defective bone marrow

microenvironment or 3. From cellular or humoral

immunosuppression of hematopoiesis.

Page 7: Aplastic and hypoproliferative anemias

ETIOLOGY

ACQUIRED CONGENITAL

Page 8: Aplastic and hypoproliferative anemias

Aplastic anemiaACQUIRED

Most cases of aplastic anemia are idiopathic and there is no history of exposure to substances known to be causative agents of the disease

Exposure to ionizing radiation – hematopoietic cells are especially susceptible to ionizing radiation. Whole body radiation of 300-500 rads can completely wipe out the bone marrow. With sublethal doses, the bone marrow eventually recovers.

Chemical agents – include chemical agents with a benzene ring, chemotherapeutic agents, and certain insecticides.

Idiosyncratic reactions to some commonly used drugs such as chloramphenicol or quinacrine.

Page 9: Aplastic and hypoproliferative anemias

Aplastic anemia Infections – viral and bacterial

infections such as infectious mononucleosis, infectious hepatitis, cytomegalovirus infections, and miliary tuberculosis occasionally lead to aplastic anemia

Pregnancy (rare) Paroxysmal nocturnal

hemoglobinuria – this is a stem cell disease in which the membranes of RBCs, WBCs and platlets have an abnormality making them susceptible to complement mediated lysis.

Other diseases – preleukemia and carcinoma

Page 10: Aplastic and hypoproliferative anemias

Aplastic anemiaCONGENITAL DISORDERS

Fanconi’s anemia – the disorder usually becomes symptomatic ~ 5 years of age and is associated with progressive bone marrow hypoplasia. Congenital defects such as skin hyperpigmentation and small stature are also seen in affected individuals.

Familial aplastic anemia – a subset of Fanconi’s anemia in which the congenital defects are absent.

Page 11: Aplastic and hypoproliferative anemias

ETIOLOGYACQUIRED CONGENITAL

1. Idiopathic2. Ionizing radiation3. Chemical agents4. Idiosynratic

reactions5. Infections6. Pregnancy7. PNH8. others

1. Fanconi,s anemia

2. Familial aplastic anemia

Page 12: Aplastic and hypoproliferative anemias

CLINICAL MANIFESTATIONS

Fatigue Heart palpitations Pallor Infections Petechiae Mucosal bleeding

Page 13: Aplastic and hypoproliferative anemias

Aplastic anemia LAB FINDINGS

Severe pancytopenia with relative lymphocytosis (lymphocytes live a long time)

Normochromic, normocytic RBCs (may be slightly macrocytic)

Mild to moderate anisocytosis and poikilocytosis

Decreased reticulocyte count Hypocellular bone marrow with >

70% yellow marrow

Page 14: Aplastic and hypoproliferative anemias

TREATMENT in untreated cases the prognosis is poor

Remove causative agent, if known Multiple transfusions Bone marrow transplant

Page 15: Aplastic and hypoproliferative anemias

Related disorders Disorders in which there is

peripheral pancytopenia, but the bone marrow is normocellular, hypercellular, or infiltrated with abnormal cellular elements Myelopthesic anemia – replacement

of bone marrow by fibrotic, granulomatous, or neoplastic cells

Page 16: Aplastic and hypoproliferative anemias

Related disorders MYELODYSPLASTIC SYNDROMES – are

primary, neoplastic stem cell disorders that tend to terminate in acute leukemia.

The bone marrow is usually normocellular, or hypercellular with evidence of qualitative abnormalities in one or more cell lines resulting on ineffective erythropoiesis and/or granulopoiesis and/or megakaryopoiesis.

The peripheral smear shows dysplastic (abnormality in development) cells including nucleated RBCs, oval macrocytes, pseudo-Pelger-Huet PMNs (hyposegmented neutrophils) with hyperchromatin clumping, hypogranulated neutrophils, and giant bizarre platlets.

HYPERSPLENISM – why can this lead to pancytopenia?

Page 17: Aplastic and hypoproliferative anemias

Pure Red Cell Aplasia Pure red cell aplasia is characterized by a

selective decrease in erythroid precursor cells in the bone marrow. WBCs and platlets are unaffected. ACQUIRED

Transitory with viral or bacterial infections Patients with hemolytic anemias may

suddenly halt erythropoiesis Patients with thymoma – T-cell mediated

responses against bone marrow erythroblasts or erythropoietin are sometimes produced.

Page 18: Aplastic and hypoproliferative anemias

Pure Red Cell Aplasia CONGENITAL

Diamond-Blackfan syndrome – occurs in young children and is progressive. It is probably due to an intrinsic or regulatory defect in the committed erythroid stem cell.

Page 19: Aplastic and hypoproliferative anemias

OTHER HYPOPROLIFERATIVE ANEMIAS

Renal disease – due to decreased erythropoietin

Endocrine deficiencies – may lead to decreased erythropoietin production. For example: hypothyroidism leads to decreased demand for oxygen from tissues; decreased androgens in males; decreased pituitary function

Page 20: Aplastic and hypoproliferative anemias
Page 21: Aplastic and hypoproliferative anemias
Page 22: Aplastic and hypoproliferative anemias

Thank you